This year's Pediatrics/Adult Congenital Heart Disease program will explore everything from basic science of channelopathic disease, the cutting-edge science of CRISPR gene editing, and stem cell biology to challenging patients cases. Experts will share the stage with rising stars in the field to discuss career development, ablation, lead extraction, and their challenges and successes.Susan Etheridge, MD, FHRS, CEPS-P
2020 Heart Rhythm has 16 sessions specifically tailored to heart rhythm specialists focused on Pediatrics/Adult Congenital Heart Disease.
Wednesday, May 6
Session Description: Arrhythmogenic (Right) Ventricular Cardiomyopathy is more challenging in children because subtle imaging or electrocardiographic changes may occur before the first. In the modern era of family- centered care, referrals for a family history of ARVC and/or genetic screening add additional complications. Even management of confirmed ARVC is controversial the asymptomatic adolescent. This session will delve into the latest understanding of the genetics and biology of ARVC and bridge those new data to inform clinical decisions and outcomes.
Session Description: Atrial fibrillation is challenging in structurally normal hearts and an exceptionally hard problem in our ACHD population. This session will discuss atrial fibrillation in the adolescent and beyond. This session will discuss ways to assess atrial fibrillation substrates and how to medically and invasively approach this challenging disease.
Thursday, May 7
Session Description: The findings in the EP lab either in the patient with complex anatomy or complex arrhythmias requires not only tremendous preoperative planning, but adjustments as the case potentially unfolds. This session will present unique approaches to ablations and device implants.
Session Description: There has been an explosion in the amount of genomic information now available for children at risk for arrhythmic deaths. In addition, there is increasing population-based health information on the incidence of SCD in the young. It is a challenge to incorporate this information into clinical practice. This is the first session where we have combined the expertise of pediatric EP with genetic counselors and should be an interactive and dynamic forum to explore these challenging topics.
Session Description: This session will review some of the challenges in diagnosing some of the rarer channelopathies. This session will also review an understanding of the drugs that effect QT interval as well as review current recommendations regarding exercise restrictions and allowances in patients with HCM.
Session Description: The decision to do nothing and watch is one of the hardest decisions and takes a fair bit of confidence in both understanding the diagnosis as well as the natural history of the condition. Often the treatment for certain conditions may be worse than the diagnosis itself. This session will review some challenging pediatric EP conditions and when cat-like vigilance and masterful nonintervention is reasonable.
Session Description: This session will review challenging cases faced by clinicians in the EP lab and how they approached them. It will also delve into how to work and learn in a collaborative spirit with our adult EP colleagues.
Session Description: The pediatric electrophysiology community has been very proactive in assessing quality outcomes for the last 3 decades. The results of catheter ablation in children are generally >90%. While a great deal of energy goes into Impact Registries is the Pediatric EP Community receiving useful information to help with QI? This session will discuss potential opportunities to improve QI ablation data analytics.
Session Description: This rapid-fire session presents typical challenges faced by junior electrophysiologist and allied professionals. It focuses on 7-minute case presentations, followed by the opportunity for a panel discussion among the assembled group. Cases are drawn from the cath lab, the operating room, and clinic. The focus of the conversation is on challenging cases and various reasonable approaches.
Friday, May 8
Session Description: This session challenges the physician around a specific and technical challenge they faced in the clinical management of a patient with either an arrhythmia or requiring a device.
Session Description: Much of how we practice has become ingrained over the course of years and decades. As the practice of pediatric EP evolves the standard of care will change. This session looks to 2020, providing a vision of where certain treatment strategies may be headed.
Session Description: Left cardiac sympathetic denervation has been used in patients with LQT who generally have had appropriate ICD shocks despite optimal medical management. Is there a role for LCSD to supplant ICDs and should this therapy be offered instead of an ICD in high risk patients for primary prevention.
Session Description: There exists a lot of controversy in the LQT population as to what is the ideal beat-blocker, ideal dose, and some evidence that not all BB are equal. Furthermore there is a lack of clarity on why a given beta-blocker may be beneficial for certain pathogenic genotypes.
Session Description: Two clinicians will Present Two Challenging Cases to Dr. Barbara Deal, senior electrophysiologist.
Saturday, May 9
Session Description: Adult congenital heart disease is increasing faster than pediatric congenital heart disease. Many of these patients are plagued by supraventricular, ventricular and bradyarrhythmias. This session is a joint session between PACES and AEPC to share expertise on the diagnosis and management of these complex dysrhythmias.
Session Description: This session delves into some of the challenges faced by clinicians in the EP lab including complex ablations and pacemaker lead implantation. A number of novel imaging technologies have been developed to help with these complex ablations. This session will review these technologies by experts in the field and discuss the challenges and opportunities. Lastly this session will review how to best utilize imaging to help localize pacer lead implantation.
This session will review challenging cases faced by clinicians in the EP lab and how they approached them. It will also delve into how to work and learn in a collaborative spirit with our adult EP colleagues.